Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,475 | 416,902 | 278,562 | 329,111 | 384,197 |
| Depreciation Amortization | 1,031,811 | 348,033 | 301,760 | 239,723 | 233,900 |
| Other Working Capital | -51,918 | -17,028 | -109,388 | -79,875 | 129,892 |
| Other Operating Activity | -108,025 | -49,003 | -49,413 | -26,658 | -110,187 |
| Operating Cash Flow | $875,343 | $698,905 | $421,521 | $462,302 | $637,802 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -102,609 | N/A | N/A | N/A | N/A |
| PPE Investments | -4,088 | -16,082 | -38,380 | -7,135 | -5,130 |
| Net Acquisitions | N/A | N/A | -1,599,422 | N/A | N/A |
| Purchase Of Investment | -4,190 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -318,149 | -268,191 | -427,745 | -139,236 | -37,662 |
| Other Investing Activity | -327,960 | -276,327 | -427,745 | -139,236 | -37,662 |
| Investing Cash Flow | $-438,847 | $-292,409 | $-2,065,547 | $-146,371 | $-42,792 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,345,212 | 3,383,107 | 1,355,193 | 1,654,904 |
| Debt Repayment | -504,153 | -1,764,858 | -2,322,420 | -1,594,915 | -2,121,071 |
| Common Stock Issued | 25,039 | 40,394 | 17,068 | N/A | N/A |
| Other Financing Activity | 37,303 | 757 | 526,477 | -56,686 | -55,501 |
| Financing Cash Flow | $-441,811 | $-378,495 | $1,604,232 | $-296,408 | $-521,668 |
| Exchange Rate Effect | -4,701 | -5,771 | -3,301 | 11,793 | 1,399 |
| Beginning Cash Position | 116,508 | 85,518 | 128,342 | 103,560 | 47,106 |
| End Cash Position | 106,390 | 107,844 | 85,247 | 134,875 | 121,847 |
| Net Cash Flow | $-10,118 | $22,326 | $-43,095 | $31,316 | $74,741 |
| Free Cash Flow | |||||
| Operating Cash Flow | 875,343 | 698,905 | 421,521 | 462,302 | 637,802 |
| Capital Expenditure | -4,088 | -16,082 | -38,380 | -7,135 | -5,480 |
| Free Cash Flow | 871,255 | 682,823 | 383,141 | 455,166 | 632,322 |